Status:
COMPLETED
KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Kliniken Essen-Mitte
Conditions:
Ovary Cancer
Fallopian Tube Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
KORE-INNOVATION is a multi-center clinical study aiming to implement and analyze an innovative care pathway to reduce perioperative complications for patients undergoing surgical treatment for ovarian...
Detailed Description
The treatment of patients with ovarian, fallopian tube or peritoneal cancer (OC) usually consists of a primary operation, followed by platinum-based chemotherapy and targeted maintenance therapy. Acco...
Eligibility Criteria
Inclusion
- Women with primary diagnosis of ovarian, fallopian tube or peritoneal cancer and primary surgical treatment (all histological subgtypes, all FIGO-stages)
- women with first recurrence of ovarian, fallopian tube or peritoneal cancer and primary surgical treatment (all histological subgtypes, all FIGO-stages)
- patients who have given and signed informed consent-forms
Exclusion
- inoperable situs
- neoadjuvant chemotherapy
- simultaneous diagnosis of secondary primary tumors (except for breast cancer)
- dementia or other psychological diseases, that impair comprehence and compliance
- pregnancy
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
465 Patients enrolled
Trial Details
Trial ID
NCT05256576
Start Date
July 1 2020
End Date
December 31 2023
Last Update
January 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Evangelische Kliniken Essen Mitte
Essen, North Rhine-Westphalia, Germany, 45136
2
Charité University Hospital Berlin
Berlin, State of Berlin, Germany, 13353